Delivery Order SPE2DB24D1021-SPE2DB25FFBEF
- Not listed
- The Defense Logistics Agency awarded a $1,810.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Qsymia 11.25 mg-69 mg capsules (30-count), a prescription weight management medication. The order was competitively awarded with no set-aside designation and is scheduled for completion by August 18, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,922.80 delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Qsymia 3.75 mg-23 mg capsules in a 30-count package. This is a firm fixed-price delivery order with an ultimate completion date of August 12, 2025, and no set-aside designation was utilized. The award represents a competitive procurement action through an open competition process. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,444.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 15 mg–92 mg capsules (30-count) on September 16, 2025, with completion targeted for September 17, 2025. This firm fixed-price delivery order utilizes no set-aside designation and represents a competitively awarded transaction under AmerisourceBergen's existing contract vehicle with DLA. The product will be performed at the contractor's location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,646.10 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count) under contract 4569035131. The delivery order, issued on August 8, 2025, with an ultimate completion date of August 11, 2025, represents a non-set-aside, competitively awarded procurement. Performance will be executed from the vendor's Conshohocken, Pennsylvania location, which serves as the company's corporate office and...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a $1,945.44 firm fixed-price delivery order for QSYMIA 11.25 mg-69 mg capsules (30-count) on July 23, 2025, with completion targeted for July 24, 2025. This non-set-aside competitive award represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. The product...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $1,133.09 on September 18, 2025, for the supply of Qsymia 7.5 mg-46 mg capsules (30-count). This is a firm fixed-price, non-set-aside contract with a completion date of September 19, 2025, and performance will be conducted at the contractor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This delivery order, awarded on August 20, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, provides for the supply of Qsymia 11.25 mg-69 mg capsules (30-count unit) with a firm fixed price ceiling value of $2,037.36. The order is scheduled for completion by August 21, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This award was not designated as a set-aside contract and was competitively awarded under an existing contract...
- The Defense Logistics Agency awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp for $1,225.31 on June 5, 2025, for the supply of Qsymia 3.75 mg-23 mg capsules (30-count package). This is a non-set-aside competitive award with an ultimate completion date of June 6, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $1,876.52 to AmerisourceBergen Drug Corp for the supply of Qsymia 7.5 mg-46 mg capsules (30-count units), a prescription medication used in weight management treatment. The contract, which was competitively awarded with no set-aside designation, was issued on August 28, 2025, with an ultimate completion date of August 29, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, utilizing...
- The Defense Logistics Agency awarded a delivery order valued at $1,071.43 to AmerisourceBergen Drug Corp for Qsymia 3.75 mg-23 mg capsules (30-count units), with performance in Conshohocken, Pennsylvania and completion by September 23, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFBEFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Qsymia 11.25 mg-69 mg capsules (30-count) valued at $1,614.09, with an ultimate completion date of September 26, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded and represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The awardee, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor providing critical medical procurement support to federal healthcare systems. This delivery order falls under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of medications, vaccines, and medical supplies to support military healthcare programs worldwide. AmerisourceBergen's federal contract portfolio demonstrates its established capability to fulfill federal medical supply requirements through open competition, with delivery orders consistently structured as firm fixed-price arrangements across various pharmaceutical therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 9/25/25 |